Der Nuklearmediziner 2002; 25(2): 101-105
DOI: 10.1055/s-2002-33279
MIBG-Szintigraphie

© Georg Thieme Verlag Stuttgart · New York

Empfehlungen zur Durchführung der MIBG- Szintigraphie bei Kindern

Leitlinie übernommen vom Paediatric Committee der European Association of Nuclear Medicine (EANM)Guidelines for MIBG-scintigraphy in childrenP.  Olivier1 , P. Colarinha2 , J. Fettich3 , S. Fischer4 , K. Hahn4 , U. Porn4 , J. Frökier5 , F. Giammarile6 , I. Gordon7 , L. Kabasakal8 , M. Mann9 , M. Mitjavila10 , A. Piepsz11 , R. Sixt 12 , J. van Velzen13
  • 1CHU Nancy, France
  • 2Instituto Portugues de Oncologia, Lisbon, Portugal
  • 3University Medical Centre Ljubljana, Slovenia
  • 4Klinik fuer Nuklearmedizin, University of Munich, Germany
  • 5Aarhus University Hospital - Skejby, Denmark
  • 6Centre Léon Bérard, Lyon, France
  • 7Great Ormond Street Hospital for Children, London, UK
  • 8Cerraphasa Tipp Fakultesi, Nukleer Tipp Ana Bilim Dali, Aksaray, Turkey
  • 9Red Cross Hospital Cape Town, South Africa
  • 10Hospital Universitário de Getafe, Madrid, Spain
  • 11AZ VUB and CHU St Pierre, Brussels, Belgium
  • 12Sahlgrenska University Hospital Oestra, Goeteborg, Sweden
  • 13liaison person ARPES
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. August 2002 (online)

Zusammenfassung

Bei den vorliegenden Empfehlungen handelt es sich um die deutsche Übersetzung der vom Paediatric Committee der European Association of Nuclear Medicine (EANM) publizierten Guidelines.

Abstract

These “Empfehlungen” are the german translation of the Guidelines on MIBG-Scintigraphy in Children, which were published by the Paediatric Committee of the European Association of Nuclear Medicine.

Literatur

  • 1 Giammarile F, Boneu A , Edeline V, Lumbroso J, Siles S, Wioland M. Guide de realisation de la scintigraphie à la méta-iodobenzylguanidine (mIBG) en oncologie pédiatrique.  Med Nucl. 2000;  24 35-41
  • 2 Shapiro B, Copp J E, Sisson J  C, Eyre P L, Wallis J, Beierwaltes W H . Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.   J Nucl Med. 1985;  26 576-585
  • 3 Sisson J C, Shulkin B L. Nuclear medicine imaging of pheochromocytoma and neuroblastoma.  Q J Nucl Med. 1999;  43 217-223
  • 4 Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel C A, Jamadar D A, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin B L, Sisson J C, Thein A, Troncone  L. Specificity of radioiodinated MIBG for neural crest tumors in childhood.  J Nucl Med. 1997;  38 1352-1357
  • 5 Khafagi  F A, Shapiro B, Fischer M, Sisson J C , Hutchinson R, Beierwaltes W H. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.  Eur J Nucl Med. 1991;  18 191-198
  • 6 Shulkin  B L, Shapiro B. Current concepts on the diagnostic use of MIBG in children.   J Nucl Med. 1998;  39 679-688
  • 7 Wieland D M, Wu J, Brown L E, Mangner T J, Swanson D P, Beierwaltes W H . Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.  J Nucl Med. 1980;  21 349-353
  • 8 Khafagi F A, Shapiro B, Gross M D. The adrenal gland. In: Maisey MN, Britton KE, Gilday DL (eds). Clinical Nuclear Medicine. Chapman & Hall, London 1989; 271-291
  • 9 Kinnier-Wilson  L M, Draper G J. Neuroblastoma, its natural history and prognosis: a study of 487 cases.  Br Med J. 1974;  3 301-307
  • 10 Young J L, Ries L G, Silverberg E, Horm J W, Miller R W. Cancer incidence, survival, and mortality for children younger than age 15 years.  Cancer. 1986;  58 (Suppl 2) 598-602
  • 11 Jacobs A, Delree M, Desprechins B, Otten J, Ferster A , Jonckheer M H, Mertens J, Ham H R, Piepsz A. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.  Pediatr Radiol. 1990;  20 157-159
  • 12 Gelfand M J. Meta-iodobenzylguanidine in children.   Semin Nucl Med. 1993;  23 231-242
  • 13 Lumbroso J D, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Leclere J G, Couanet D, Bayle C, Caillaud J M, Lemerle J. et al . Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans.  Prog Clin Biol Res. 1988;  271 689-705
  • 14 Parisi M T, Greene M K, Dykes T M, Moraldo T V, Sandler E D, Hattner R S. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.  Invest Radiol. 1992;  27 768-773
  • 15 Moyes J, McCready V R, Fullbrook  A. Neuroblastoma MIBG in its diagnosis and management. Springer 1989
  • 16 Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn S L. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.  J Pediatr Hematol Oncol. 1999;  21 13-18
  • 17 Hoefnagel C A, De Kraker J, Valdes Olmos R  A, Voute P A. [131I]MIBG as a first line treatment in advanced neuroblastoma.  Q J Nucl Med. 1995;  39 (Suppl 1) 61-64
  • 18 Lumbroso J, Hartmann O, Schlumberger  M. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. „Societe Francaise d'Oncologie Pediatrique” and Nuclear Medicine Co-investigators.  J Nucl Biol Med. 1991;  35 220-223
  • 19 Mairs R J. Neuroblastoma therapy using radiolabelled [131I]meta- iodobenzylguanidine ([131I]MIBG) in combination with other agents.  Eur J Cancer. 1999;  35 1171-1173
  • 20 Gordon I, Peters A M, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma - the pitfalls of iodine-123- MIBG scans.  J Nucl Med. 1990;  31 129-134
  • 21 Solanki K K, Bomanji J, Moyes J, Mather S J, Trainer P J, Britton K E. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).  Nucl Med Commun. 1992;  13 513-521
  • 22 Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwidlet J. A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine.  Eur J Nucl Med. 1990;  17 127-129
  • 23 Stabin M G, Gelfand M J. Dosimetry of pediatric nuclear medicine procedures.  Q J Nucl Med. 1998;  42 93-112
  • 24 Pintelon H, Jonckheer M H, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety.  Nucl Med Commun. 1994;  15 664-666
  • 25 Rufini V, Fisher G A, Shulkin B L, Sisson J C, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.  J Nucl Med. 1996;  37 1464-1468
  • 26 Rufini V, Giordano A, Di Giuda D, Petrone A, Deb G, De Sio L, Donfrancesco A, Troncone L. [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.  Q J Nucl Med. 1995;  4 25-28
  • 27 Gelfand M J, Elgazzar A H, Kriss V M, Masters P R, Golsch G J. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.  J Nucl Med. 1994;  35 1753-1757
  • 28 Nakajo M, Shapiro B, Copp J , Kalff V, Gross M D, Sisson J C, Beierwaltes W H. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.  J Nucl Med. 1983;  24 672-682
  • 29 Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C. Refining interpretation of MIBG scans in children.  J Nucl Med. 1994;  35 803-810
  • 30 Lumbroso J, Giammarile F, Hartmann O, Bonnin F, Parmentier C. Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children.  Q J Nucl Med. 1995;  39 17-20

Prof. Dr. med. K. Hahn

Klinik und Poliklinik für Nuklearmedizin

Ludwig-Maximilians-Universität München

Ziemssenstr. 1

80336 München

Telefon: +49-89-61 60-24 42

Fax: +49-89-51 60-44 88

eMail: hahn@nuk.med.uni-muenchen.de

    >